RABIFLUX – DSR

RABIFLUX – DSR is a powerful gastroprotective and acid-reducing formulation specifically designed to manage acid reflux, heartburn, gastroesophageal reflux disease (GERD), and related digestive disorders. Combining Rabeprazole, a proton pump inhibitor, and Domperidone, a prokinetic agent, this medicine provides dual-action relief by reducing stomach acid production while promoting better gastrointestinal motility.

The Rabeprazole component works by blocking acid production at its source in the stomach lining, providing fast and effective relief from heartburn, acidity, and stomach discomfort. Meanwhile, Domperidone enhances gastric emptying, preventing nausea, bloating, and vomiting, and helping to restore normal digestive function. This combination ensures comprehensive management of both acid-related symptoms and delayed gastric emptying, making RABIFLUX – DSR highly effective for patients experiencing persistent digestive issues.

RABIFLUX – DSR is particularly beneficial for individuals suffering from GERD, peptic ulcers, acid indigestion, or functional dyspepsia. It provides rapid symptomatic relief while also supporting long-term gastrointestinal health when taken under the guidance of a healthcare professional. The dual-action formulation helps reduce the risk of recurrence of acidity-related disorders and improves overall digestive comfort.

This medicine is well-tolerated and suitable for adult patients, offering a convenient and reliable solution for managing complex digestive problems. Its consistent use helps patients regain comfort, prevent complications, and enjoy normal daily activities without digestive discomfort.

Trusted for its proven efficacy and safety, RABIFLUX – DSR is an ideal choice for comprehensive acid control and digestive support, ensuring that patients achieve optimal gastrointestinal wellness and long-lasting relief from acid-related disorders.